|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Patento numeris | 2589669 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13152518.0 |
| Europos patento paraiškos padavimo data | 2011-04-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-05-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-10-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 323502 P | 2010-04-13 | US |
| (72) |
Chu, Tom, US
Essioux, Laurent, FR
Germer, Soren, US
Lopatin, Uri, US
Shulman, Nancy, US
Thommes, James, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | Single nucleotide polymorphisms that predict HCV treatment outcomes |
| Single nucleotide polymorphisms that predict HCV treatment outcomes |